Response to Shami et al.'Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong …

UK Buchwald, T Folaranmi, T Weiss - Human Vaccines & …, 2021 - Taylor & Francis
The recently published article by Shami et al. describes a cost-effectiveness analysis of
sequential pneumococcal vaccination with 13-valent pneumococcal conjugate vaccine …

[PDF][PDF] Response to Shami et al.'Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in …

UK Buchwald, T Folaranmi, T Weiss - 2020 - researchgate.net
The recently published article by Shami et al. describes a cost-effectiveness analysis of
sequential pneumococcal vaccination with 13-valent pneumococcal conjugate vaccine …

Response to Shami et al.'Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong …

UK Buchwald, T Folaranmi, T Weiss - Human Vaccines & …, 2020 - europepmc.org
The recently published article by Shami et al. describes a cost-effectiveness analysis of
sequential pneumococcal vaccination with 13-valent pneumococcal conjugate vaccine …

[HTML][HTML] Response to Shami et al.'Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults …

UK Buchwald, T Folaranmi, T Weiss - Human Vaccines & …, 2021 - ncbi.nlm.nih.gov
The recently published article by Shami et al. describes a cost-effectiveness analysis of
sequential pneumococcal vaccination with 13-valent pneumococcal conjugate vaccine …

Response to Shami et al.'Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong …

UK Buchwald, T Folaranmi… - Human vaccines & …, 2021 - pubmed.ncbi.nlm.nih.gov
The recently published article by Shami et al. describes a cost-effectiveness analysis of
sequential pneumococcal vaccination with 13-valent pneumococcal conjugate vaccine …